Mr. David S Knapp, M.D. Internal Medicine - Rheumatology Medicare: Medicare Enrolled Practice Location: 106 Grey Pl, Mount Juliet, TN 37122 Phone: 615-414-9025 |
News Archive
Data from a small cohort published OncoTargets and Therapy today shows that the Paradigm Cancer Diagnostic Test (PCDx) performed better than Foundation Medicine's FoundationOne test across a number of key clinical variables, including turnaround time (TAT) and clinically actionable biomarker targets.
Madagascar's unprecedented outbreak of pneumonic plague is slowing down but the response must be sustained, WHO cautioned on Monday (November 27).
ThromboGenics NV, a biopharmaceutical company focused on the discovery and development of innovative treatments for eye disease, cardiovascular disease and cancer, announces that the pooled results from the successful microplasmin MIVI-TRUST Phase III program were presented today at the EURETINA (European Society of Retina Specialists) Congress in Paris, France.
A new vaccine for meningitis, MenAfriVac, offers hope of an escape from one of the world's deadliest, most disabling and infectious diseases, the BBC writes. The vaccine was developed by non-governmental organization PATH in partnership with the WHO and created specifically for Africa.
› Verified 5 days ago